Citations

Showing 10 of 108094 citations.

Osteochondritis Dissecans in the Knee of Skeletally Immature Patients: Rates of Persistent Pain, Osteoarthritis, and Arthroplasty at Mean 14-Years’ Follow-Up
Sanders, Thomas L. , Pareek, Ayoosh , Milbrandt, Todd A. , Levy, Bruce A. , Saris, Daniël B.F. , Krych, Aaron J. , Milbrandt, Todd A , Krych, Aaron J , Hevesi, Mario , Stuart, Michael J.

Mayo Clinic

CARTILAGE | July 12, 2018 | Volume: 11 | Issue: 3 | Pages: 291-299

10.1177/1947603518786545 | PMID 29998745 Get It

Objective Osteochondritis dissecans (OCD) is a knee disorder of predominately pediatric populations. Because of low incidence, it has traditionally been difficult to study OCD. The purpose of this study was to report long-term outcomes of skeletally immature OCD lesions and determine risk factors for persistent knee pain at final follow-up. Design A geographic database of more than 500,000 patients was reviewed to identify patients with knee OCD. Clinical course including operative management, persistent knee pain, and total knee arthroplasty (TKA) were analyzed through review of radiographs, magnetic resonance images, and physician notes. Results A total of 95 skeletally immature patients (70 male, 25 female, mean age 12.5 ± 2.0 years) were followed for a mean of 14 years (range, 2-40 years). Fifty-three patients were treated operatively and 42 were treated nonoperatively. At final follow-up, 13 patients noted persistent knee pain, 8 treated operatively versus 5 treated nonoperatively. Risk factors for knee pain were female gender, patellar lesions, and unstable lesions. Four patients (8%) treated operatively and 2 patients (5%) treated nonoperatively developed symptomatic osteoarthritis at a mean of 28.6 years following diagnosis. Three patients underwent TKA at a mean age of 52 years, significantly younger than that observed for primary TKA at our institution ( P = 0.004). Conclusions Skeletally immature OCD patients have promising histories, with an estimated 14% risk of persistent knee pain, 6% symptomatic osteoarthritis, and 3% conversion to TKA at 14 years’ mean follow-up. Females, patellar lesions, and unstable lesions demonstrated increased persistent knee pain risk. Patients with OCD undergo TKA at a significantly younger age than the general population.
Adenomatous Neuroendocrine Tumors of the Middle Ear: A Multi-institutional Investigation of 32 Cases and Development of a Staging System
Marinelli, John P. , Cass, Stephen P., Mann, Scott E. , Haynes, David S. , Hunter, Jacob B. , Sweeney, Alex D. , Pelosi, Stanley, Willcox, Thomas O., O’Connell, Brendan P., Rivera, Michael , Lane, John I. , Carlson, Matthew L. , Isaacson, Brandon , Hunter, Jacob B

Mayo Clinic

Otology & Neurotology | July 12, 2018 | Volume: 39 | Issue: 8 | Pages: e712-e721

10.1097/mao.0000000000001905 | PMID 30001283 Get It

Objective: To date, less than 150 cases of middle ear adenomatous neuroendocrine tumors (MEANTs) have been reported in the English literature. The objective of this study was to provide a contemporary analysis of these rare lesions and develop a consensus-driven staging system. Study Design: Multi-institutional retrospective histopathologic, radiologic, and clinical review. Setting: Six tertiary referral centers. Patients: Thirty-two patients with pathologically confirmed MEANT. Intervention: Surgical resection, adjuvant therapy. Main Outcome Measures: Clinical manifestations, outcomes, staging system. Results: Patients commonly presented with progressive conductive or mixed hearing loss (90%), aural fullness (50%), and tonal tinnitus (46%). Pulsatile tinnitus (16%), carcinoid syndrome (4%), and facial nerve paresis (4%) were less commonly observed. MEANTs frequently mimicked temporal bone paraganglioma (31%) and cholesteatoma (15%) at presentation. According to a novel T/N/M/S staging system (S = secretory tumor) proposed herein, there were 6 (19%) T1, 19 (59%) T2, and 7 (22%) T3 MEANTs. T3 tumors were significantly more likely to undergo subtotal or near total resection compared with lower staged tumors secondary to adherence to critical neurovascular structures such as the petrous internal carotid artery and facial nerve (p = 0.027). Patients with T3 MEANTs were more likely to experience multiple recurrences, require adjuvant therapy with a somatostatin analogue, or develop permanent facial nerve paresis compared with lower staged tumors. At last follow up, no patients with T1 MEANTs had developed recurrence, whereas 37% (7/19) of patients with T2 MEANT and 57% (4/7) of patients with T3 MEANT experienced either disease recurrence after gross total resection (GTR) or regrowth of known residual tumor requiring additional surgery at a median duration of 72 months (95% CI, 24–84). Conclusions: Patients with MEANTs can present with nonspecific symptomatology that overlaps with more commonly encountered middle ear lesions. MEANT exhibits a proclivity for recurrence according to T-stage and long-term clinical follow up is necessary, particularly for advanced stage tumors.
Outcomes of Patients With Cirrhosis Undergoing Orthopedic Procedures
Parikh, Neehar D. , Tapper, Elliot B. , Mathur, Amit K. , Parikh, Neehar D , Chang, Yu‐Hui

Mayo Clinic

Journal of Clinical Gastroenterology | July 12, 2018 | Volume: 53 | Issue: 9 | Pages: e356-e361

10.1097/mcg.0000000000001091 | PMID 30001287 Get It

Introduction: The population of patients with cirrhosis is growing and shifting toward a more elderly demographic and thus are at risk of developing orthopedic complications. There is lack of data on safety of orthopedic procedures in this population. Methods: We performed an analysis of the Nationwide Inpatient Sample from 2005 to 2011 for patients undergoing hip arthroplasty, knee arthroplasty, and spinal laminectomy/fusion, stratified by presence of cirrhosis. The primary endpoint was in-hospital mortality and secondary endpoints included length of stay (LOS) and costs. Results: There were 693,610 inpatient stays for orthopedic procedures conducted during the study period, with 3014 (0.43%) patients coded as having cirrhosis. Patients with cirrhosis had a lower median age (62 vs. 66 y; P<0.001) and were more likely to be male (52.3% vs. 41.1%; P<0.001). The inpatient mortality rate was significantly higher in patients with cirrhosis (2.4% vs. 0.4%; P<0.001) as was median LOS (4 vs. 3 d; P<0.001) and mean costs ($19,321 vs. $18,833; P<0.001). Patients with decompensated cirrhosis (vs. compensated cirrhosis) had significantly higher inpatient mortality rates (5.8% vs. 1.1%; P<0.001) with higher LOS and costs (P<0.001). On multivariable analysis, cirrhosis was associated with an increased risk of mortality (odds ratio, 4.22; 95% confidence interval, 2.92-6.10). Hospital cirrhosis volume was inversely associated with mortality, while hospital orthopedic procedure volumes had an inconsistent impact on outcomes. Conclusions: Inpatient orthopedic procedures in patients with cirrhosis result in high postoperative mortality, LOS, and costs. Careful patient selection is warranted to optimize cirrhosis patient postoperative outcomes.
Post-ischaemic exuberant left ventricular mass: thrombus vs. tumour—case report
Viscuse, Paul V. , Bartlett, David J. , Foley, Thomas A. , Michelena, Héctor I.

Mayo Clinic

European Heart Journal - Case Reports | July 12, 2018 | Volume: 2 | Issue: 3 | Pages: No page available

10.1093/ehjcr/yty077 | PMID 31020155 Get It

Reply to “Low prevalence of diabetes with chronic complications in patients with Takotsubo syndrome”
Desai, Rupak , Singh, Sandeep , Goyal, Hemant , Dhoble, Abhijeet , Deshmukh, Abhishek , Kumar, Gautam , Sachdeva, Rajesh , Sachdeva, Rajesh , Desai, Rupak

Mayo Clinic

Clinical Cardiology | July 12, 2018 | Volume: 41 | Issue: 8 | Pages: 1036-1037

10.1002/clc.23024 | PMID 29998519 Get It

Elevated ST2 levels are associated with antibody‐mediated rejection in heart transplant recipients
Grupper, Avishay , AbouEzzeddine, Omar F. , Maleszewski, Joseph J. , Grupper, Ayelet , Geske, Jennifer R. , Kremers, Walter K. , Kushwaha, Sudhir S. , Pereira, Naveen L. , Kremers, Walter K , Geske, Jennifer , AbouEzzeddine, Omar F

Mayo Clinic

Clinical Transplantation | July 12, 2018 | Volume: 32 | Issue: 9 | Pages: No page available

10.1111/ctr.13349 | PMID 29998506 Get It

AbstractSoluble ST2 (sST2) is a novel biomarker of inflammation and fibrosis. Elevated sST2 levels (≥35 ng/mL) are associated with worse outcomes in patients with heart failure (HF). There are sparse data regarding the significance of sST2 levels after heart transplantation (HTx). The study aims were to evaluate trends in soluble ST2 levels after the resolution of HF status with HTx and association between post‐HTx sST2 levels and outcomes. Plasma sST2 levels were measured at baseline (median [IQR] of 118 days pre‐HTx) and 12 months post‐HTx in 62 subjects who were stratified into two groups by post‐HTx sST2 levels < or ≥35 ng/mL: “Group 1” or “Group 2,” respectively. Plasma sST2 levels were elevated in 58% of patients pre‐HTx and in 50% of patients post‐HTx. There was no association between elevated sST2 levels before and after HTx, and no significant differences in baseline characteristics between Group 1 and Group 2 patients. Group 2 as compared to Group 1 HTx recipients had significantly higher incidence of antibody‐mediated rejection (AMR) for the entire post‐transplant follow‐up period (32% vs 4%, P = 0.006). There was no association between post‐HTx sST2 level status and other post‐HTx outcomes including survival. In conclusion, elevated plasma sST2 levels after HTx are associated with increased risk for AMR.
Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation
Narayanan, Praveena , Mara, Kristin C. , Izzy, Manhal , Dierkhising, Ross , Watt, Kymberly D. , Mara, Kristin, Mara, Kristin C , Heimbach, Julie K. , Allen, Alina M.

Mayo Clinic

Transplantation | July 12, 2018 | Volume: 103 | Issue: 1 | Pages: e14-e21

10.1097/tp.0000000000002317 | PMID 29994981 Get It

Background Hepatic steatosis is strongly associated with cardiovascular disease in the general population. Whether recurrent or de novo, it can occur in the allograft, but the impact on survival and long-term clinical outcomes remains unclear. In this study, we aim to determine both the frequency and impact of allograft steatosis on long-term posttransplant outcomes. Methods A retrospective review of 588 adult liver transplant (LT) recipients (1999-2006) was performed. Cox regression analysis (time-dependent) was used to evaluate differences in time to steatosis post-LT, patient survival, and cardiovascular outcomes. Results Mean age 51.9 ± 10.6 years, 64.6% males, underlying nonalcoholic steatohepatitis (NASH) (9.4%), previous tobacco (52%), pre-LT diabetes mellitus (30.3%), pre-LT hypertension (23.2%), and known cardiovascular disease (9.7%). Overall, 254 recipients developed allograft steatosis (at 10 years: 77.6% NASH recipients, 44.7% Non-NASH recipients). Risk factors for allograft steatosis were female sex (hazard ratio [HR], 1.47; 95% confidence interval [CI], 1.09-2.00; P = 0.014), hepatitis C virus diagnosis (HR, 2.49; 95% CI, 1.77-3.94; P < 0.001), and time-dependent BMI (per unit: HR, 1.08; 95% CI, 1.05-1.10; P < 0.001). Allograft steatosis was not associated with post-LT survival (P = 0.25) nor cardiovascular events (HR, 1.08; 95% CI, 0.73-1.59; P = 0.70). Underlying NASH associated with cardiovascular events (HR, 2.04; 95% CI, 1.37-3.04; P < 0.001). Conclusions Allograft steatosis is common but not associated with survival or cardiovascular events in this study. Larger prospective studies are needed to better define the natural history of allograft steatosis.
Family Caregivers’ Confidence Caring for Relatives in Hospice Care at Home: An Exploratory Qualitative Study
Soroka, Jacek T. , Froggatt, Katherine , Morris, Sara

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | July 11, 2018 | Volume: 35 | Issue: 12 | Pages: 1540-1546

10.1177/1049909118787779 | PMID 29996659 Get It

Objectives: Although the experiences of family caregivers have received attention, little research has specifically explored caregivers’ confidence. Evidence shows that caregivers of hospice patients do not feel confident or prepared to care for relatives or friends who die at home. Aim: We aimed to elicit the views, feelings, and experiences of primary caregivers who provide unpaid care to dying family members in the home setting to better understand what contributes to their confidence during end-of-life care. Design: The exploratory, cross-sectional design involved semistructured, in-depth interviews. A narrative analysis that focused on form and content was chosen to analyze the data. Participants: Sixteen bereaved caregivers (14 individuals and 1 brother/sister dyad) from the midwestern United States who received support from 1 hospice participated in the study. Results: Four storylines running longitudinally through the interviews were identified as shaping, giving meaning to, and contextualizing caregivers’ confidence: values/relationships, stories of terminal illness, needs, and support. Caregivers’ confidence is shaped by the terminal illness of the person for whom they care and caregivers’ values and relationships. It is also influenced by their needs and the sources and strength of support they receive. Conclusions: This research developed understanding about family provision of end-of-life care at home. Better comprehension of caregivers’ experiences can help professional hospice and palliative care staff to understand what aids caregivers to be more confident.
Monoclonal Antibodies for Myeloma: Make It Easy!
Kumar, Shaji

Mayo Clinic

Journal of Oncology Practice | July 11, 2018 | Volume: 14 | Issue: 7 | Pages: 423-424

10.1200/jop.18.00350 | PMID 29996067 Get It